We present a case in which the undiagnosed condition of sarcoidosis complicated the staging of bilateral, subtype-discordant renal cell carcinoma. Initially thought to have metastatic renal cell carcinoma based on computed tomography imaging and referred for immunotherapy, a positron emission tomography/computed tomography scan demonstrated different levels of radiotracer activity in the primary site and the presumed pulmonary metastatic sites. The patient underwent bilateral partial nephrectomies and was ultimately diagnosed with stage T1 bilateral renal cell carcinoma and sarcoidosis. This case highlights the need to consider concurrent medical conditions that can lead to false positive results when evaluating for metastatic disease with imaging studies as well as the importance of evaluating the levels of radiotracer activity between different sites.
CASE REPORT
A 48 year-old Caucasian female presented to an urgent care clinic with a three-day history of left lower quadrant abdominal pain, which was diagnosed as diverticulitis. Her past medical history was significant for hypertension, chronic back pain, and uterine fibroids for which she had undergone an abdominal hysterectomy. She denied any family history of malignancy. A computed tomography (CT) scan at the time of presentation incidentally demonstrated solid renal masses in both kidneys, measuring 4 x 4 x 5 centimeters on the right and 3 x 3 x 3.5 centimeters on the left as well as bilateral pulmonary nodules (figures 1 and 2). Her creatinine was 0.6. A CT-guided needle biopsy of the right lower pole renal mass demonstrated renal cell carcinoma (RCC) (figure 3). A biopsy of the pulmonary nodules was attempted but was unsuccessful in obtaining tissue adequate for diagnosis.
After referral to our tertiary referral center for consideration of interleukin-2 (IL-2) immunotherapy in the setting of presumed metastatic RCC, a fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT scan was obtained. This demonstrated increased FDG activity in nodal stations from the mediastinum to the pelvis (maximum standardized uptake value [maxSUV] range of 6.1 to 9.3), bilateral pulmonary nodules (maxSUV 3.2), and multiple bony sites (maxSUV range of 8.8 to 12.6) (figure 4, 5). However, neither renal mass demonstrated significant metabolic activity. As a point of reference, the blood pool activity was 2.83.
The difference in metabolic activity between the primary site of disease and the presumed metastatic disease suggested the possibility of two separate disease processes. Because of this possibility as well as the lack of a pathologic diagnosis of metastatic disease, the patient underwent an open right partial nephrectomy and right paracaval lymph node dissection through a flank incision. The excision plane of the partial nephrectomy entered the collecting system, which was closed with a bolster. There were no post-operative complications and her creatinine was 0.6 one month after surgery. Pathology of the renal mass demonstrated a stage T1b, chromophobe cell renal carcinoma, which distorted the adjacent calyx but did not invade the calyceal urothelium (figure 6). Pathologic margins were negative. The excised lymph node contained multiple non-caseating granulomata (figure 7).
Three months later, an open left heminephrectomy was performed through a flank incision for a stage T1a, clear cell renal cell carcinoma (figure 8). The defect in the collecting system was closed primarily using a bolster, and, again, the pathology specimen demonstrated negative surgical margins and a tumor localized to the renal cortex. Her post-operative course was uneventful. Finally, a biopsy of several lung nodules was performed at an outside hospital; the biopsy demonstrated non-caseating granulomata and she was diagnosed with sarcoidosis.
A repeat CT scan of the chest, abdomen, and pelvis performed 12 months after the last surgery demonstrated stable pulmonary nodules and lymphadenopathy. Postoperative changes were seen in the kidneys, without evidence of residual or recurrent RCC (figure 9). Her creatinine was 1.22. In this case, the undiagnosed condition of sarcoidosis complicated the staging of bilateral RCC. Sarcoidosis is usually suspected based on the clinical presentation and radiographic evidence, such as mediastinal lymphadenopathy; the diagnosis is confirmed by the presence of non-caseating granulomata on biopsy specimens. Approximately 30-60% of cases, however, are diagnosed based on radiologic findings in an asymptomatic patient [6] .
RCC
The precise role of FDG-PET in the diagnosis and staging of RCC remains somewhat elusive, with the highest utility in detecting visceral, lymph node and bony disease [7] . This case illustrates the fact that coexisting conditions can result in false positive results. The PET/CT for this patient showed different levels of radiotracer activity in the primary site and the presumed metastatic site. It was only after the functional information provided by the metabolic imaging was added to the diagnostic evaluation that additional testing became warranted.
Percutaneous renal biopsies are generally not used in the diagnostic workup of a suspected malignant renal mass because of the possibility of sampling error, difficulty distinguishing oncocytoma from RCC, and because biopsy results do not routinely give enough additional information beyond that provided by imaging studies to alter the course of management [8] . There are exceptions to this general rule; patients suspected of having a disease process that would be managed medically (lymphoma, renal abscess, or metastatic renal cell carcinoma) are good candidates for a percutaneous biopsy. Risks of a percutaneous renal biopsy include bleeding (which rarely requires aggressive intervention such as transfusion or embolization), infection, and arteriovenous fistulas. Tumor tract seeding has been reported but is very rare [8, 9] ; the reported incidence of tumor tract seeding for percutaneous biopsy of abdominal tumors is less than 0.01% [10] . In this case, the indication for biopsy was to guide medical management in a patient with presumptive metastatic disease based on imaging.
In addition to the presence of sarcoidosis complicating the staging of this patient's disease, the case is interesting because of the presence of two different subtypes of renal cell carcinoma. Bilateral, subtype-concordant RCC is likely the result of multiple de novo primary malignancy occurrences rather than metastasis to the contralateral kidney [2] . In this patient, the presence of bilateral, subtypediscordant renal cell carcinoma seems to support this theory.
Undiagnosed coexisting conditions, such as sarcoidosis, can result in false positive findings on CT and PET/CT scans when evaluating patients with renal masses for metastatic disease. The levels of radiotracer activity at each site should be evaluated because significant differences in activity may suggest separate disease processes. (4a, 4b) . Note the lack of increased metabolic activity in the renal masses (4a, 4b; white arrows) whereas the mediastinal lymphadenopathy demonstrates a maximum standardized uptake value (maxSUV) of 8.3 in the left hilar region and 6.1 in the right hilar region (4a, 4b; white arrowheads). Different levels of metabolic activity are also noted between the right renal mass and a paracaval lymph node (4c, 4d; curved black arrow) and an aortocaval lymph node (4e, black arrow), which had a maxSUV of 9.1. Sagittal images demonstrate increased metabolic activity in the left clavicular head with a maxSUV of 12.6 (4f, 4g; grey arrow) and a lymph node posterior to the thyroid with a maxSUV of 7.7 (4f, 4g; grey arrowhead). 
